Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04965558

Enrollment

1000

Registered

2021-07-16

Start date

2004-01-01

Completion date

2030-01-01

Last updated

2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Features and Outcome

Brief summary

The investigators aimed to observe the clinical features and outcome in patients with osseomuscular type of Wilson's disease from a large cohort during long-term follow-up

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 65 Years

Healthy volunteers

Inclusion criteria

* genetically diagnosed WD patients

Exclusion criteria

* Deny follow-up

Design outcomes

Primary

Measure	Time frame	Description
Serum ceruloplasmin	From 2004 through 2030	Serum ceruloplasmin levels were collected among patients with wilson disease. After confirming a non-Gaussian distribution, the reference range of serum ceruloplasmin level was determined.
Urinary Copper Excretion	From 2004 through 2030	The measurement of 24-hour urine copper excretions were collected and measured.

Countries

China

Contacts

Primary ContactYi Dong

dongyi720@zju.edu.cn+8618367129345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026